Order Article Reprints

Mistry PK, Kishnani PS, Balwani M, Charrow JM, Hull J, Weinreb NJ, Cox TM. The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11, 5158. Journal of Clinical Medicine. 2023; 12(9):3269. https://doi.org/10.3390/jcm12093269

Mistry, Pramod K., Priya S. Kishnani, Manisha Balwani, Joel M. Charrow, Judy Hull, Neal J. Weinreb, and Timothy M. Cox. 2023. "The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11, 5158" Journal of Clinical Medicine 12, no. 9: 3269. https://doi.org/10.3390/jcm12093269

Mistry, P. K., Kishnani, P. S., Balwani, M., Charrow, J. M., Hull, J., Weinreb, N. J., & Cox, T. M. (2023). The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11, 5158. Journal of Clinical Medicine, 12(9), 3269. https://doi.org/10.3390/jcm12093269